Despite the low TMB of MPM and the lack of predictivity of PD-L1 to immunotherapy response, several analyses of the genomic landscape of MM suggested interesting signs to understand the basis for a response to ICIs. The gene discussed is CD274; the disease is Miyoshi myopathy.